CATHAY SECURITIES CORPORATION GLOBAL GENOMICS IMMUNOLOGY & MEDICAL REVCATHAY SECURITIES CORPORATION GLOBAL GENOMICS IMMUNOLOGY & MEDICAL REVCATHAY SECURITIES CORPORATION GLOBAL GENOMICS IMMUNOLOGY & MEDICAL REV

CATHAY SECURITIES CORPORATION GLOBAL GENOMICS IMMUNOLOGY & MEDICAL REV

No trades
See on Supercharts

Key stats

Assets under management (AUM)
‪1.88 B‬TWD
Fund flows (1Y)
‪−547.32 M‬TWD
Dividend yield (indicated)
Discount/Premium to NAV

About CATHAY SECURITIES CORPORATION GLOBAL GENOMICS IMMUNOLOGY & MEDICAL REV

Issuer
Cathay Financial Holdings Co., Ltd.
Brand
Cathay
Expense ratio
1.05%
Inception date
Nov 22, 2021
Index tracked
Solactive Global Genomics Immunology and Medical Revolution Index - Benchmark TR Net
Management style
Passive
ISIN
TW0000089804
1 90%() 2 1 () 100%

Classification

Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Health care equipment & services
Strategy
Vanilla
Weighting scheme
Market cap
Selection criteria
Market cap

Returns

1 month3 monthsYear to date1 year3 years5 years
Price performance
NAV total return

What's in the fund

As of June 26, 2024
Exposure type
StocksBonds, Cash & Other
Health Technology
Stocks99.13%
Health Technology95.97%
Health Services1.72%
Commercial Services1.44%
Bonds, Cash & Other0.87%
Cash0.87%
Stock breakdown by region
84%12%3%
North America84.47%
Europe12.05%
Asia3.47%
Latin America0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings

Dividends

Dividend payout history

Assets under management (AUM)

Fund Flows